Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:40 AM
Ignite Modification Date:
2025-12-25 @ 1:40 AM
NCT ID:
NCT06272994
Eligibility Criteria:
Inclusion Criteria:
* Adult (age greater than or equal to 18) patients admitted/transferred to the Vanderbilt University Medical Center (VUMC) Medical Intensive Care Unit (MICU) from the VUMC Emergency Department or from a hospital floor within 48 hours of admission.
* Suspicion for pneumonia on admission (defined as an indication for antibiotics of "respiratory infection" and/or an order for a respiratory culture i.e., sputum culture, tracheal aspirate culture, or bronchoalveolar lavage (BAL) culture).
* No topical nasal decolonization during hospitalization prior to collection of MRSA nasal swab PCR.
* Must match both of the following in either order:
* The patient has been admitted to and physically located in the MICU.
* The patient has received a continuing vancomycin order, or a pharmacokinetics consult for a continuing vancomycin order, no later than 24 hours following their physical admission to the MICU.
Exclusion Criteria:
* Hospital stay of longer than 48 hours prior to MICU admission.
* Known to be a prisoner
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06272994
Study Brief:
Protocol Section:
NCT06272994